Consolidated Statement Of Income

COSMOS Pharmaceutical Corporation - Filing #7727098

Concept 2017-06-01 to
2018-02-28
2016-06-01 to
2017-02-28
Consolidated statement of income
Statement of income
Net sales
410,771,000,000 JPY
370,567,000,000 JPY
Cost of sales
329,978,000,000 JPY
296,132,000,000 JPY
Operating expenses
Selling, general and administrative expenses
65,013,000,000 JPY
57,060,000,000 JPY
Operating expenses
Ordinary profit (loss)
17,650,000,000 JPY
19,109,000,000 JPY
Operating profit (loss)
15,778,000,000 JPY
17,374,000,000 JPY
Net sales
Gross profit (loss)
80,792,000,000 JPY
74,434,000,000 JPY
Cost of sales
Extraordinary income
65,000,000 JPY
1,551,000,000 JPY
Non-operating income
Interest income
59,000,000 JPY
64,000,000 JPY
Other
548,000,000 JPY
587,000,000 JPY
Non-operating income
2,447,000,000 JPY
2,400,000,000 JPY
Selling, general and administrative expenses
Non-operating expenses
Interest expenses
66,000,000 JPY
74,000,000 JPY
Other
41,000,000 JPY
25,000,000 JPY
Non-operating expenses
575,000,000 JPY
665,000,000 JPY
Extraordinary losses
154,000,000 JPY
409,000,000 JPY
Profit (loss) before income taxes
17,560,000,000 JPY
20,251,000,000 JPY
Gross profit
Extraordinary income
Extraordinary losses
Loss on disaster
JPY
204,000,000 JPY
Loss on retirement of non-current assets
25,000,000 JPY
25,000,000 JPY
Income taxes
5,686,000,000 JPY
7,671,000,000 JPY
Profit (loss)
11,874,000,000 JPY
12,579,000,000 JPY
Profit (loss) attributable to owners of parent
11,874,000,000 JPY
12,579,000,000 JPY
Profit attributable to
Other comprehensive income
Valuation difference on available-for-sale securities
0 JPY
-1,000,000 JPY
Remeasurements of defined benefit plans, net of tax
13,000,000 JPY
77,000,000 JPY
Other comprehensive income
13,000,000 JPY
76,000,000 JPY
Comprehensive income
11,888,000,000 JPY
12,655,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
11,888,000,000 JPY
12,655,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.